VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NYT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NYTThe New York Times Company
$61.89$10.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. NYT
  4. Financial Ratios

The New York Times Company (NYT) Financial Ratios

Latest Ratios: P/E Ratio 29.6x · EV/EBITDA 18.0x · ROE 17.3%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

NYT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$10.1B$11.5B$8.6B$8.1B$5.4B$8.1B$8.7B$5.4B$3.7B$3.0B$2.2B
Enterprise Value$9.8B$11.2B$8.5B$7.9B$5.3B$7.9B$8.5B$5.2B$3.7B$3.1B$2.3B
P/E Ratio →29.6133.2229.4134.9931.2136.8786.2838.3029.72616.6773.89
P/S Ratio3.564.053.343.352.353.924.882.972.131.811.39
P/B Ratio5.005.614.484.603.395.286.554.593.573.392.56
P/FCF18.2620.8022.6324.0147.7134.7233.0237.3146.731551.2333.76
P/OCF17.2019.5921.0222.5136.0030.2529.2028.3823.6835.0522.98

P/E links to full P/E history page with 30-year chart

NYT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—3.983.283.242.283.804.752.882.131.851.49
EV / EBITDA18.0320.6019.1321.1817.8723.5334.2821.4014.9813.0313.26
EV / EBIT21.8424.8522.0525.9222.2327.0772.8827.2618.3222.5633.28
EV / FCF—20.4222.2323.2946.2833.6332.1336.1046.881585.5936.04

NYT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin50.8%50.8%49.4%48.5%47.6%49.9%46.2%45.5%45.8%63.2%59.5%
Operating Margin16.0%16.0%13.6%11.4%8.7%12.9%9.9%9.7%10.9%10.5%7.2%
Net Profit Margin12.2%12.2%11.4%9.6%7.5%10.6%5.6%7.7%7.2%0.3%1.9%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE17.3%17.3%15.9%13.8%11.1%15.3%8.0%12.6%13.0%0.5%3.5%
ROA11.8%11.8%10.6%8.9%6.8%9.0%4.6%6.5%5.9%0.2%1.3%
ROIC18.7%18.7%16.0%14.0%11.1%16.9%12.6%12.8%14.1%13.5%7.9%
ROCE19.8%19.8%16.2%13.6%10.2%14.0%10.2%11.1%11.9%10.2%6.2%

NYT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.020.020.020.020.040.040.040.050.240.280.29
Debt / EBITDA0.090.090.110.120.200.190.210.231.021.051.42
Net Debt / Equity—-0.10-0.08-0.14-0.10-0.17-0.18-0.150.010.070.17
Net Debt / EBITDA-0.38-0.38-0.34-0.66-0.55-0.77-0.95-0.720.050.280.84
Debt / FCF—-0.38-0.40-0.73-1.43-1.09-0.89-1.210.1534.352.28
Interest Coverage387.68387.68378.01299.41296.00378.78159.7850.086.564.641.58

Net cash position: cash ($255M) exceeds total debt ($49M)

NYT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.541.541.531.281.151.701.721.641.331.802.00
Quick Ratio1.541.541.531.281.151.701.721.641.331.802.00
Cash Ratio0.960.960.920.740.611.181.220.990.911.181.38
Asset Turnover—0.940.910.890.910.810.770.870.800.800.71
Inventory Turnover———————————
Days Sales Outstanding—37.5835.2236.4834.4040.9737.5942.9846.4440.2746.31

NYT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield1.1%1.0%1.0%0.9%1.0%0.6%0.4%0.6%0.7%0.9%1.2%
Payout Ratio32.1%32.1%28.2%29.9%32.7%20.6%38.4%22.6%21.0%605.3%89.1%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield3.4%3.0%3.4%2.9%3.2%2.7%1.2%2.6%3.4%0.2%1.4%
FCF Yield5.5%4.8%4.4%4.2%2.1%2.9%3.0%2.7%2.1%0.1%3.0%
Buyback Yield1.6%1.4%1.0%0.5%1.9%0.0%0.0%0.0%0.0%0.0%0.7%
Total Shareholder Yield2.7%2.4%1.9%1.4%3.0%0.6%0.4%0.6%0.7%0.9%1.9%
Shares Outstanding—$165M$166M$166M$167M$169M$168M$168M$167M$164M$163M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

SBC dilution and margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Margin Expansion with Seasonal Volatility

NYT's operating margin expanded from 8.1% in 2024Q1 to 15.5% in 2026Q2, per reported financials, while gross margin improved to 51.8%, indicating strong pricing power and operating leverage.

The sequential dip in Q1 margins (46.2% gross, 9.2% operating in 2025Q1) suggests seasonality in subscription and advertising revenue, but the overall upward trend reflects successful digital transition. Net margin at 12.3% in 2026Q2 is supported by low interest expense and minimal debt, though SBC nearly tripled over the period, which may understate true earnings quality.

ROIC Cyclicality Masks Underlying Improvement

ROIC swung from 2.4% in 2024Q1 to 7.0% in 2025Q4, as per balance sheet data, with 2026Q2 at 4.9%, reflecting seasonal revenue patterns and asset growth.

The 10-quarter range of 2.4% to 7.0% indicates that quarterly ROIC is heavily influenced by seasonality, but the trend suggests improving capital efficiency as digital revenue scales. ROE similarly fluctuates, peaking at 6.5% in Q4 quarters, implying that annualized returns are likely higher than any single quarter suggests. Investors should focus on full-year figures to assess true capital compounding.

Working Capital Efficiency with Subscription Float

DSO improved from 32 days in 2024Q1 to 28 days in 2026Q2, per reported figures, while DPO remained stable around 33-36 days, indicating efficient receivables management.

The absence of inventory (DIO not reported) reflects the digital asset-light model, and the negative CCC (implied) suggests NYT collects cash from subscribers before paying suppliers, a structural advantage. Deferred revenue growth from $174.9M to $211.2M over the period, as per balance sheet data, provides interest-free float and enhances cash conversion.

Minimal Leverage with Exceptional Coverage

NYT's debt-to-equity is negligible at 0.02, with interest coverage exceeding 579x in 2025Q4, as per financial statements, indicating a fortress balance sheet.

The only debt appears in Q4 quarters (likely seasonal), but D/EBITDA of 0.26 is trivial, and interest coverage of 579x suggests debt service is not a constraint. This conservative leverage provides ample flexibility for buybacks and dividends, though investors should monitor if debt is used for future acquisitions.

Liquidity Strengthens with Digital Shift

Current ratio improved from 1.25 in 2024Q1 to 1.58 in 2026Q2, per balance sheet data, with quick ratio identical, indicating no inventory dependence.

The steady improvement in liquidity reflects growing cash reserves and deferred revenue, which acts as a liability but also a prepaid subscription buffer. Under stress, the asset-light model and high FCF margin (34.8% in 2026Q2) would likely sustain operations without external financing, though Q1 seasonality could temporarily pressure liquidity.

P/E Misleads in Subscription Model

NYT's trailing P/E of 31.0 appears rich, but forward P/E of 22.7 and PEG of 1.09, per valuation data, suggest the market is pricing in sustained growth.

The most commonly misapplied ratio is P/E, because it fails to capture the subscription-based revenue model's high visibility and low capital intensity. EV/EBITDA of 18.9 is more appropriate, but even that understates value given the negative working capital cycle and deferred revenue float. Investors should use EV/FCF or EV/EBITDA with adjustments for SBC to better reflect true earning power.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open NYT Terminal

NYT Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NYT — Frequently Asked Questions

Quick answers to the most common questions about buying NYT stock.

What is The New York Times Company's P/E ratio?

The New York Times Company's current P/E ratio is 29.6x. The historical average is 34.5x. This places it at the 50th percentile of its historical range.

What is The New York Times Company's EV/EBITDA?

The New York Times Company's current EV/EBITDA is 18.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.2x.

What is The New York Times Company's ROE?

The New York Times Company's return on equity (ROE) is 17.3%. The historical average is 11.6%.

Is NYT stock overvalued?

Based on historical data, The New York Times Company is trading at a P/E of 29.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is The New York Times Company's dividend yield?

The New York Times Company's current dividend yield is 1.08% with a payout ratio of 32.1%.

What are The New York Times Company's profit margins?

The New York Times Company has 50.8% gross margin and 16.0% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does The New York Times Company have?

The New York Times Company's Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.